Title:
ERROR CODE DETECTION METHOD, DEVICE AND SYSTEM AND COMPUTER-READABLE STORAGE MEDIUM
Document Type and Number:
WIPO Patent Application WO/2018/059436
Kind Code:
A1
Abstract:
Disclosed are an error code detection method, device and system, and a computer-readable storage medium, which are applied to a transmission end of a flexible Ethernet (FLexE) network structure. The method comprises: the transmission end checking an information block to be sent within a current overhead frame coverage range according to a pre-set check strategy, to acquire a check reference value corresponding to the information block to be sent; the sending end storing the check reference value corresponding to the information block to be sent within the current overhead frame coverage range into a pre-set error code check field in a next overhead frame; and the transmission end sending a check reference value corresponding to the information block to be sent within the current overhead frame coverage range together with the next overhead frame.
Inventors:
LIU FENG (CN)
Application Number:
PCT/CN2017/103658
Publication Date:
April 05, 2018
Filing Date:
September 27, 2017
Export Citation:
Assignee:
ZTE CORP (CN)
International Classes:
H04L12/24
Foreign References:
| CN104426631A | 2015-03-18 |
Other References:
"Overhead processing of FlexE and FlexO atomic function;C2109", ITU-T DRAFT ; STUDY PERIOD 2013-2016,20160906INTERNATIONAL TELECOMMUNICATION UNION, GENEVA ; CH, vol. 11/15, 19 September 2016 (2016-09-19), pages 1 - 3, XP044181599
"Flex Ethernet Implementation Agreement", IA OIF-FLEXE-01.0, 31 March 2016 (2016-03-31), XP55509044
See also references of EP 3522448A4
"Flex Ethernet Implementation Agreement", IA OIF-FLEXE-01.0, 31 March 2016 (2016-03-31), XP55509044
See also references of EP 3522448A4
Attorney, Agent or Firm:
CHINA PAT INTELLECTUAL PROPERTY OFFICE (CN)
Download PDF:
Previous Patent: SCORING SYSTEM FOR COMBAT SPORTS
Next Patent: TREATMENT CANCERS USING COMBINATION COMPRISING PARP INHIBITORS
Next Patent: TREATMENT CANCERS USING COMBINATION COMPRISING PARP INHIBITORS